Matthew Harrison
Stock Analyst at Morgan Stanley
(3.48)
# 930
Out of 5,099 analysts
709
Total ratings
49.19%
Success rate
4.46%
Average return
Main Sectors:
Stocks Rated by Matthew Harrison
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ARGX argenx SE | Maintains: Overweight | $1,070 → $1,110 | $890.11 | +24.70% | 27 | Dec 4, 2025 | |
| PHVS Pharvaris | Maintains: Overweight | $37 → $41 | $23.68 | +73.14% | 16 | Dec 4, 2025 | |
| REGN Regeneron Pharmaceuticals | Downgrades: Equal-Weight | $767 | $726.21 | +5.62% | 57 | Dec 3, 2025 | |
| ZNTL Zentalis Pharmaceuticals | Maintains: Equal-Weight | $8 → $4 | $1.42 | +181.69% | 5 | Nov 12, 2025 | |
| BMRN BioMarin Pharmaceutical | Maintains: Overweight | $104 → $98 | $53.70 | +82.50% | 23 | Oct 28, 2025 | |
| BIIB Biogen | Maintains: Equal-Weight | $144 → $149 | $177.55 | -16.08% | 55 | Oct 10, 2025 | |
| MRNA Moderna | Maintains: Equal-Weight | $31 → $32 | $29.03 | +10.23% | 26 | Oct 10, 2025 | |
| DNLI Denali Therapeutics | Maintains: Overweight | $33 → $30 | $17.57 | +70.75% | 13 | Aug 18, 2025 | |
| INSM Insmed | Downgrades: Equal-Weight | $112 → $126 | $189.85 | -33.63% | 19 | Aug 13, 2025 | |
| LEGN Legend Biotech | Maintains: Overweight | $81 → $83 | $23.36 | +255.31% | 13 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $6 → $4 | $0.81 | +393.83% | 6 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $460 → $439 | $444.64 | -1.27% | 41 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $15 → $20 | $22.20 | -9.91% | 38 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Positive | $215 | $194.07 | +10.78% | 1 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $130 → $135 | $121.34 | +11.26% | 42 | Apr 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $6.2 → $6 | $3.16 | +89.87% | 10 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $5 | $1.40 | +257.14% | 5 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $160 → $178 | $138.82 | +28.22% | 1 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $56 | $31.12 | +79.95% | 2 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $57 → $55 | $27.58 | +99.42% | 2 | Jan 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $10 → $3 | $1.30 | +130.77% | 10 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $8 → $11 | $29.57 | -62.80% | 9 | Jun 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $7 | $2.60 | +169.23% | 18 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $32 | $31.24 | +2.43% | 27 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $21 → $19 | $4.33 | +338.80% | 3 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $2 → $1 | $2.51 | -60.16% | 3 | Mar 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $13 → $10 | $20.62 | -51.50% | 9 | Mar 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $27 → $8 | $13.80 | -42.03% | 9 | Feb 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $57 → $44 | $32.33 | +36.10% | 28 | Feb 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $13 | $4.94 | +163.16% | 3 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $140 → $80 | $31.28 | +155.75% | 4 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $100 → $60 | $5.80 | +934.48% | 4 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $203 → $216 | $95.74 | +125.62% | 8 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $7 → $5 | $4.01 | +24.69% | 13 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $5 | $1.81 | +176.24% | 6 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $178 → $182 | $225.18 | -19.18% | 8 | Dec 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $12 → $9 | $24.56 | -63.36% | 13 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $30 → $40 | $54.70 | -26.87% | 6 | Nov 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $279 → $282 | $315.38 | -10.58% | 38 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $220 → $210 | $404.46 | -48.08% | 7 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $55 → $52 | $25.78 | +101.71% | 5 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $175 → $173 | $206.54 | -16.24% | 3 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $156 → $120 | $36.00 | +233.33% | 17 | Feb 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $145 → $148 | $10.60 | +1,296.23% | 19 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $88 → $82 | $97.62 | -16.00% | 4 | Nov 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $71 → $66 | $51.21 | +28.88% | 4 | Oct 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $43 → $39 | $5.56 | +601.44% | 4 | Aug 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $51 → $46 | $38.26 | +20.23% | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $33 → $35 | $7.18 | +387.47% | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $207 → $275 | $993.64 | -72.32% | 2 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19 | $2.95 | +544.07% | 1 | Jun 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $67 → $62 | $13.06 | +374.73% | 12 | Mar 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $16 → $17 | $17.56 | -1.77% | 3 | Feb 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $89 → $83 | $95.17 | -12.79% | 1 | Jan 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Equal-Weight | $10 | $60.32 | -83.42% | 4 | Sep 10, 2018 |
argenx SE
Dec 4, 2025
Maintains: Overweight
Price Target: $1,070 → $1,110
Current: $890.11
Upside: +24.70%
Pharvaris
Dec 4, 2025
Maintains: Overweight
Price Target: $37 → $41
Current: $23.68
Upside: +73.14%
Regeneron Pharmaceuticals
Dec 3, 2025
Downgrades: Equal-Weight
Price Target: $767
Current: $726.21
Upside: +5.62%
Zentalis Pharmaceuticals
Nov 12, 2025
Maintains: Equal-Weight
Price Target: $8 → $4
Current: $1.42
Upside: +181.69%
BioMarin Pharmaceutical
Oct 28, 2025
Maintains: Overweight
Price Target: $104 → $98
Current: $53.70
Upside: +82.50%
Biogen
Oct 10, 2025
Maintains: Equal-Weight
Price Target: $144 → $149
Current: $177.55
Upside: -16.08%
Moderna
Oct 10, 2025
Maintains: Equal-Weight
Price Target: $31 → $32
Current: $29.03
Upside: +10.23%
Denali Therapeutics
Aug 18, 2025
Maintains: Overweight
Price Target: $33 → $30
Current: $17.57
Upside: +70.75%
Insmed
Aug 13, 2025
Downgrades: Equal-Weight
Price Target: $112 → $126
Current: $189.85
Upside: -33.63%
Legend Biotech
Aug 12, 2025
Maintains: Overweight
Price Target: $81 → $83
Current: $23.36
Upside: +255.31%
Aug 12, 2025
Maintains: Overweight
Price Target: $6 → $4
Current: $0.81
Upside: +393.83%
Aug 5, 2025
Maintains: Equal-Weight
Price Target: $460 → $439
Current: $444.64
Upside: -1.27%
Jul 29, 2025
Maintains: Equal-Weight
Price Target: $15 → $20
Current: $22.20
Upside: -9.91%
Jul 15, 2025
Initiates: Positive
Price Target: $215
Current: $194.07
Upside: +10.78%
Apr 25, 2025
Maintains: Overweight
Price Target: $130 → $135
Current: $121.34
Upside: +11.26%
Apr 11, 2025
Maintains: Equal-Weight
Price Target: $6.2 → $6
Current: $3.16
Upside: +89.87%
Mar 12, 2025
Maintains: Overweight
Price Target: $15 → $5
Current: $1.40
Upside: +257.14%
Feb 21, 2025
Maintains: Buy
Price Target: $160 → $178
Current: $138.82
Upside: +28.22%
Feb 18, 2025
Upgrades: Buy
Price Target: $56
Current: $31.12
Upside: +79.95%
Jan 31, 2025
Maintains: Buy
Price Target: $57 → $55
Current: $27.58
Upside: +99.42%
Nov 26, 2024
Downgrades: Underweight
Price Target: $10 → $3
Current: $1.30
Upside: +130.77%
Jun 21, 2024
Maintains: Equal-Weight
Price Target: $8 → $11
Current: $29.57
Upside: -62.80%
May 9, 2024
Upgrades: Equal-Weight
Price Target: $7
Current: $2.60
Upside: +169.23%
Mar 26, 2024
Maintains: Underweight
Price Target: $32
Current: $31.24
Upside: +2.43%
Aug 14, 2023
Maintains: Equal-Weight
Price Target: $21 → $19
Current: $4.33
Upside: +338.80%
Mar 27, 2023
Maintains: Underweight
Price Target: $2 → $1
Current: $2.51
Upside: -60.16%
Mar 3, 2023
Maintains: Underweight
Price Target: $13 → $10
Current: $20.62
Upside: -51.50%
Feb 28, 2023
Downgrades: Equal-Weight
Price Target: $27 → $8
Current: $13.80
Upside: -42.03%
Feb 27, 2023
Maintains: Equal-Weight
Price Target: $57 → $44
Current: $32.33
Upside: +36.10%
Jan 24, 2023
Maintains: Overweight
Price Target: $15 → $13
Current: $4.94
Upside: +163.16%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $140 → $80
Current: $31.28
Upside: +155.75%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $100 → $60
Current: $5.80
Upside: +934.48%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $203 → $216
Current: $95.74
Upside: +125.62%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $7 → $5
Current: $4.01
Upside: +24.69%
Jan 24, 2023
Maintains: Overweight
Price Target: $7 → $5
Current: $1.81
Upside: +176.24%
Dec 6, 2022
Maintains: Overweight
Price Target: $178 → $182
Current: $225.18
Upside: -19.18%
Nov 14, 2022
Maintains: Equal-Weight
Price Target: $12 → $9
Current: $24.56
Upside: -63.36%
Nov 7, 2022
Maintains: Equal-Weight
Price Target: $30 → $40
Current: $54.70
Upside: -26.87%
Nov 4, 2022
Maintains: Overweight
Price Target: $279 → $282
Current: $315.38
Upside: -10.58%
Oct 28, 2022
Maintains: Equal-Weight
Price Target: $220 → $210
Current: $404.46
Upside: -48.08%
May 4, 2022
Maintains: Equal-Weight
Price Target: $55 → $52
Current: $25.78
Upside: +101.71%
Apr 6, 2022
Maintains: Equal-Weight
Price Target: $175 → $173
Current: $206.54
Upside: -16.24%
Feb 1, 2022
Maintains: Overweight
Price Target: $156 → $120
Current: $36.00
Upside: +233.33%
Jan 7, 2022
Maintains: Equal-Weight
Price Target: $145 → $148
Current: $10.60
Upside: +1,296.23%
Nov 29, 2021
Maintains: Equal-Weight
Price Target: $88 → $82
Current: $97.62
Upside: -16.00%
Oct 12, 2021
Maintains: Equal-Weight
Price Target: $71 → $66
Current: $51.21
Upside: +28.88%
Aug 18, 2021
Maintains: Overweight
Price Target: $43 → $39
Current: $5.56
Upside: +601.44%
Aug 16, 2021
Maintains: Equal-Weight
Price Target: $51 → $46
Current: $38.26
Upside: +20.23%
Aug 16, 2021
Maintains: Equal-Weight
Price Target: $33 → $35
Current: $7.18
Upside: +387.47%
Aug 5, 2021
Maintains: Overweight
Price Target: $207 → $275
Current: $993.64
Upside: -72.32%
Jun 24, 2021
Initiates: Buy
Price Target: $19
Current: $2.95
Upside: +544.07%
Mar 8, 2021
Maintains: Overweight
Price Target: $67 → $62
Current: $13.06
Upside: +374.73%
Feb 24, 2021
Maintains: Equal-Weight
Price Target: $16 → $17
Current: $17.56
Upside: -1.77%
Jan 6, 2020
Maintains: Equal-Weight
Price Target: $89 → $83
Current: $95.17
Upside: -12.79%
Sep 10, 2018
Assumes: Equal-Weight
Price Target: $10
Current: $60.32
Upside: -83.42%